RSNA 2017 News

Optellum, Mirada present lung cancer study at RSNA 2017

By staff writers
November 28, 2017

Artificial intelligence (AI) software developer Optellum and imaging software developer Mirada Medical have partnered on deep learning and presented a lung cancer study resulting from their collaboration at RSNA 2017 in Chicago.

Led by Dr. Sarim Ather, PhD, who also presented the study findings at the RSNA meeting, researchers from Oxford University Hospitals in the U.K. assessed CT texture analysis as a tool for lung nodule follow-up. Radiologists often struggle to determine if a lung nodule detected with CT is cancerous, leading to an indeterminate diagnosis that may require up to a two-year follow-up to monitor growth.

The Optellum and Mirada are using AI-based decision-support software to improve patient management and reduce unnecessary follow-up procedures. It uses deep learning and provides an objective risk score of nodule malignancy learned from a database of tens of thousands of CT scans with known diagnoses, allowing clinicians to stratify lung nodule patients earlier, according to the companies.

The software will be featured in the Mirada Medical booth (No. 6520) and the Quantitative Imaging Reading Room (QRR013) at RSNA 2017.

Mirada's deep-learning contours match human-drawn contours
Imaging software developer Mirada Medical revealed during the American Society for Radiation Oncology (ASTRO) annual meeting that contours drawn using...
Optellum unveils lung cancer analysis software
Artificial intelligence software developer Optellum said it will showcase a prototype of its deep learning-based lung nodule risk stratification software...
Mirada showcases XD:PACS at RSNA 2016
Imaging software developer Mirada Medical is highlighting its XD:PACS products at RSNA 2016 in Chicago.
Philips, Mirada sign distribution deal
Philips Healthcare and imaging software developer Mirada Medical have signed an agreement for Philips to distribute Mirada's RTx and Workflow Box software...
Mirada launches nuclear medicine software at RSNA 2015
Imaging software developer Mirada Medical launched its new XD Nuclear Medicine software at RSNA 2015 in Chicago.
Former Philips CEO joins Mirada Medical
Mirada Medical announced that Gene Saragnese, former CEO of the imaging business at Philips Healthcare, has joined its board of directors as nonexecutive...

Copyright © 2017

Last Updated np 11/29/2017 5:36:41 PM